EKF Diagnostics company News and Trends items

The new Altair™ 240 clinical chemistry analyser fulfills a need for a fully automated and cost-effective, bench-top platform supported by the reliable and respected Stanbio Chemistry reagent menu. Built on 54 years of clinical chemistry expertise, the fully automated system with LIS bi-directional connectivity is easy to use, as either a main or back-up analyser, and is ...

The new Altair™ 240 clinical chemistry analyzer fulfills an international market need for a fully automated bench-top platform supported by the reliable and respected Stanbio Chemistry reagent menu. The fully automated system with LIS bi-directional connectivity is capable of performing up to 480 tests per hour*. In addition to being supported by EKF’s broad menu of Stan...

EKF subsidiary, Selah Genomics'' newly introduced PrecisionPath™ next generation sequencing (NGS) technology cancer test will be a key focus on Booth #19141. This first commercially available NGS panel molecular test priced under US$1000, which was recently launched in partnership with Greenville Health systems (GHS), paves the way for accessible, low-cost personalized m...

In addition to demonstrating success of current products, including Stanbio''s ß-HB assay technology and EKF Molecular''s PointMan™ technology, new products has been introduced at AACC. These latest introductions are a result of EKF''s recent acquisition of Separation Technology Inc. (STI) and DiaSpect Medical. Accurate and specific ketoacidosis results : ...

Immediate hemoglobin results The new DiaSpect Tm hemoglobin analyzer is a palm-sized point of care analyzer that is fast, easy to use and reliable in all climate conditions as it combines laboratory quality performance with unmatched measurement speed and extensive battery life. In addition to its accuracy of result, DiaSpect Tm is extremely robust since it has n...

On Stand K77, EKF will discuss new additions to its Stanbio range of liquid-stable clinical chemistry reagents (Liquicolor® and Liqui-UV®) which are designed for maximum stability and ease of use. These include a new diabetes biomarker test that provides a 2-3 week indicator of average blood glucose - the Stanbio Chemistry Glycated Serum Protein (GSP) LiquiColor® test as...

The new Stanbio Chemistry Procalcitonin (PCT) LiquiColor® Assay is fast, accurate and convenient. The test provides a precise result, which correlates well with established methodology, within 10 minutes and requires just 20 µL of sample. The reagents may be used on almost any liquid-based chemistry analyzer with open-channel capability. In addition, the reagent kit, cal...

In a scientific poster entitled, ‘Non-invasive analysis for T790M mutations of EGFR using a selective amplification method'' [1], researchers from the Kanazawa University Hospital (Kanazawa, Japan) presented a study aiming to develop a blood-based, non-invasive approach to detecting the epidermal growth factor receptor (EGFR) T790M mutation. This is associated with EGFR ...

More than eight out of ten US patients are treated in the community, and as many as 60 percent of all patients with solid tumors do not respond to first-line treatment. This results in further treatment cycles, higher cost, elevated toxicity and, perhaps most importantly, lost time. A tool that significantly improves the prognostication for patients by bringing center of...

EKF''s Premium Partnership Program (PPP) will provide its participating distributors with unique access to EKF''s diagnostics product and specialist industry knowledge. Benefits include local training and Master Class events providing distributors and customer groups with direct access to EKF product experts. The EKF Support Centre will provide an online resource allowin...